Vaxcyte Inc

Organisation

825 Industrial Road, San Carlos, CA, United States, 94070

Headquarters

Employees

Health Technology

Industry

Grant Pickering

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Price

Target

Vaxcyte Inc (PCVX) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Vaxcyte Inc (PCVX) share price will touch around $109 in next 12-months.

Currently 15 wall-street analysts regularly analyze the financials of Vaxcyte Inc on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Vaxcyte Inc (PCVX) have a share price target of $109. This median of share price forecast represents a 92.34% upside from the latest price of $56.67 as on 14.03.26.

Vaxcyte Inc (PCVX) Share Price Forecast

Home

US Stocks

Vaxcyte Inc (PCVX)

Vaxcyte Inc Stock Forecast

Vaxcyte Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Vaxcyte Inc (PCVX): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Vaxcyte Inc's share price and its median forecast price. As on 14.03.26, the difference is -50.52%

Vaxcyte Inc Forecast and Target Price

Vaxcyte Inc (PCVX) Share Price Forecast

Vaxcyte Inc (PCVX) Price vs Consensus Price Target

Vaxcyte Inc (PCVX) Share Price Forecast v/s Share Price Today

Vaxcyte Inc (PCVX): Difference between Current Price & Median Forecasted Price

Vaxcyte Inc (PCVX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price